MacroGenics
MGNX
109 hedge funds and large institutions have $125M invested in MacroGenics in 2026 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 29 increasing their positions, 28 reducing their positions, and 9 closing their positions.
1,264% more call options, than puts
Call options by funds: $600K | Put options by funds: $44K
256% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 9
94% more capital invested
Capital invested by funds: $64.2M → $125M (+$60.6M)
24% more funds holding
Funds holding: 88 → 109 (+21)
4.87% more ownership
Funds ownership: 63.05% → 67.92% (+4.9%)
4% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 28
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$3.98M |
| 2 |
Two Sigma Investments
New York
|
+$3.26M |
| 3 |
Millennium Management
New York
|
+$1.75M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.58M |
| 5 |
DP
Diadema Partners
Morristown,
New Jersey
|
+$1.28M |
Top Sellers
MGNX Hedge Fund Activity: Q1 2026 in Review
109 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2026, worth a combined $125M — up 94% from $64.2M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new MGNX positions and 9 closed out — a net gain of 23 holders — while 29 added to existing stakes and 28 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $3.98M. The largest seller was Jefferies Financial Group, exiting entirely with an estimated $2.96M sold.
- 109 institutional investors held MacroGenics (MGNX) as of Q1 2026, up from 88 in Q4 2025.
- Funds reported $125M of MacroGenics stock for Q1 2026, up 94% quarter-over-quarter.
- 32 funds opened new MacroGenics positions in Q1 2026 and 9 closed out, a net change of +23 holders.
- The largest MacroGenics buyer in Q1 2026 was RA Capital Management, an estimated $3.98M added.
- The largest MacroGenics seller in Q1 2026 was Jefferies Financial Group, an estimated $2.96M sold.
Based on aggregated 13F filings for Q1 2026.